ClinicalMind Acquires 11TEN Innovation Partners, Uniting Cutting-Edge Medical Communications with Strategic Consulting to Drive Innovation in Life Sciences

NEW YORK, April 23, 2024 /PRNewswire-PRWeb/ — ClinicalMind, LLC (CM), a premier healthcare marketing and communications company, today announced the acquisition of 11TEN Innovation Partners (11TEN), a leading strategy consulting firm with a robust healthcare innovation ecosystem. This strategic move combines CM’s expertise in medical communications and training with 11TEN’s capabilities in commercial strategy and innovation consulting, offering an unparalleled end-to-end service for healthcare and life science companies.

“We are extremely excited to be bringing 11TEN into the CM family,” said Jeanne Martel, CEO of CM. “Their teams of talented, experienced strategists and visionaries are helping accelerate healthcare innovation in novel and structured ways. CM, in turn, can align our strategic communications, instructional design, and technology expertise to the strategies that 11TEN develops, providing clients with a seamless, integrated experience. I look forward to working with James and the entire 11TEN team as we move forward.”

Keep Reading: https://www.prweb.com/releases/clinicalmind-acquires-11ten-innovation-partners-uniting-cutting-edge-medical-communications-with-strategic-consulting-to-drive-innovation-in-life-sciences-302124477.html

< Older Post

Newer Post >

September GBG Report Now Available – Federal Funding Insights for Georgia Life Sciences Members

September 11, 2025

Members are invited to join G2G’s Monthly GBG Reporting Service Webinar on September 18, 2025 . The first portion ( 12:00–12:30 PM ET ) is free and open to all, offering a high-level overview of current federal funding trends. The second half ( 12:30–1:00 PM ET ) is a premium consultation available only to Georgia Life Sciences members, offering direct access to G2G’s expert team—who have helped secure over $550 million in non-dilutive government funding since 2007. Register here: https://www.g2gconsulting.com/event/non-dilutive-funding-g2gs-monthly-gbg-reporting-service-webinar-14-3/2025-09-18/ Key opportunities this month include DARPA’s Expedited Research Innovation System for CBRN threat defense technologies, BARDA’s I-CREATE diagnostic funding and VANGUARD biomanufacturing tools development (each offering up to $200,000), NIAID tuberculosis and influenza research units (up to $1.5–$2.5 million annually), DoD’s $4 million Advanced Medical Monitor development through MTEC, and multiple SBIR opportunities for sensors and field-deployable diagnostics (up to $209,575 for Phase I awards). The September GBG report highlights 13 immunology and infectious disease opportunities, 10 cognitive and brain health programs, and several biotechnology and biomanufacturing initiatives across federal agencies including the Army, ARPA-H, BARDA, and NSF. Georgia Life Sciences members can access the complete 29-page report with detailed deadlines and eligibility requirements [insert link or portal instructions here]. GLS members can access the full 29-page report with deadlines and submission details by logging into your member portal.